Granulocyte colony-stimulating factor induces in vitro lymphangiogenesis

Biochemical and Biophysical Research Communications

Volumn 436, Issue 4, 2013, Pages 565-570

  Lee, Ae Sin ^a   Kim, Dal ^a   Wagle, Susbin Raj ^a   Lee, Jung Eun ^a   Jung, Yu Jin ^a   Kang, Kyung Pyo ^a,b   Lee, Sik ^a,b   Park, Sung Kwang ^a,b   Kim, Won ^a,b,c  

^a Chonbuk National University Medical School   (South Korea)

^b Chonbuk National University Medical School and Hospital   (South Korea)

^c NONE   (South Korea)

Author keywords

Granulocyte colony stimulating factor; Lymphangiogenesis; Lymphangiogenic factor; Lymphatic endothelial cell

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; THORACIC DUCT;

GRANULOCYTE-COLONY STIMULATING FACTOR; LYMPHANGIOGENESIS; LYMPHANGIOGENIC FACTOR; LYMPHATIC ENDOTHELIAL CELL;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LYMPHANGIOGENESIS; PHOSPHORYLATION; PROTEIN KINASES;

MUS;

EID: 84880045829     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.062     Document Type: Article

References (31)

1. Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science 1985, 229:16-22.
2. Thomas J., Liu F., Link D.C. Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor. Curr. Opin. Hematol. 2002, 9:183-189.
3. Danova M., Barni S., Del Mastro L., Danesi R., Pappagallo G.L. Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors. Expert Rev. Anticancer Ther. 2011, 11:1303-1313.
4. Bath P.M., Sprigg N. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database Syst. Rev. 2007, CD005207.
5. England T.J., Gibson C.L., Bath P.M. Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: a systematic review. Brain Res. Rev. 2009, 62:71-82.
6. Ghorbani M., Moallem S., Abnous K., Tabatabaee Yazdi S.A., Movassaghi A.R., Azizzadeh M., Mohamadpour A.H. The effect of granulocyte colony-stimulating factor administration on carbon monoxide neurotoxicity in rats. Drug Chem. Toxicol. 2013, 36:102-108.
7. Schneider A., Kruger C., Steigleder T., Weber D., Pitzer C., Laage R., Aronowski J., Maurer M.H., Gassler N., Mier W., Hasselblatt M., Kollmar R., Schwab S., Sommer C., Bach A., Kuhn H.G., Schabitz W.R. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 2005, 115:2083-2098.
8. Urdzikova L., Likavcanova-Masinova K., Vanecek V., Ruzicka J., Sedy J., Sykova E., Jendelova P. Flt3 ligand synergizes with granulocyte-colony-stimulating factor in bone marrow mobilization to improve functional outcome after spinal cord injury in the rat. Cytotherapy 2011, 13:1090-1104.
9. England T.J., Abaei M., Auer D.P., Lowe J., Jones D.R., Sare G., Walker M., Bath P.M. Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial. Stroke 2012, 43:405-411.
10. Ribatti D. Angiogenic activity of classical hematopoietic cytokines. Leuk. Res. 2012, 36:537-543.
11. Bussolino F., Wang J.M., Defilippi P., Turrini F., Sanavio F., Edgell C.J., Aglietta M., Arese P., Mantovani A. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989, 337:471-473.
12. Kojima S., Tadenuma H., Inada Y., Saito Y. Enhancement of plasminogen activator activity in cultured endothelial cells by granulocyte colony-stimulating factor. J. Cell. Physiol. 1989, 138:192-196.
13. Iwata Y., Fujimoto Y., Morino T., Sugimoto K., Ohkubo K., Kadohira T., Fukushima K., Kitahara H., Komuro I., Kobayashi Y. Effects of stem cell mobilization by granulocyte colony-stimulating factor on endothelial function after sirolimus-eluting stent implantation: a double-blind, randomized, placebo-controlled clinical trial. Am. Heart J. 2013, 165:408-414.
14. Bocchietto E., Guglielmetti A., Silvagno F., Taraboletti G., Pescarmona G.P., Mantovani A., Bussolino F. Proliferative and migratory responses of murine microvascular endothelial cells to granulocyte-colony-stimulating factor. J. Cell. Physiol. 1993, 155:89-95.
15. Valdembri D., Serini G., Vacca A., Ribatti D., Bussolino F. In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF. FASEB J. 2002, 16:225-227.
16. Colotta F., Bussolino F., Polentarutti N., Guglielmetti A., Sironi M., Bocchietto E., De Rossi M., Mantovani A. Differential expression of the common beta and specific alpha chains of the receptors for GM-CSF, IL-3, and IL-5 in endothelial cells. Exp. Cell Res. 1993, 206:311-317.
17. Shojaei F., Wu X., Qu X., Kowanetz M., Yu L., Tan M., Meng Y.G., Ferrara N. G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proc. Natl. Acad. Sci. USA 2009, 106:6742-6747.
18. Zhao Q., Sun C., Xu X., Zhou J., Wu Y., Tian Y., Ma A., Liu Z. Early use of granulocyte colony stimulating factor improves survival in a rabbit model of chronic myocardial ischemia. J. Cardiol. 2013, 61:87-94.
19. Lee A.S., Lee J.E., Jung Y.J., Kim D.H., Kang K.P., Lee S., Park S.K., Lee S.Y., Kang M.J., Moon W.S., Kim H.J., Jeong Y.B., Sung M.J., Kim W. Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. Kidney Int. 2013, 83:50-62.
20. Kerjaschki D., Huttary N., Raab I., Regele H., Bojarski-Nagy K., Bartel G., Krober S.M., Greinix H., Rosenmaier A., Karlhofer F., Wick N., Mazal P.R. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat. Med. 2006, 12:230-234.
21. Raica M., Ribatti D. Targeting tumor lymphangiogenesis: an update. Curr. Med. Chem. 2010, 17:698-708.
22. Makinen T., Jussila L., Veikkola T., Karpanen T., Kettunen M.I., Pulkkanen K.J., Kauppinen R., Jackson D.G., Kubo H., Nishikawa S., Yla-Herttuala S., Alitalo K. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 2001, 7:199-205.
23. Fiorentini S., Luganini A., Dell'Oste V., Lorusso B., Cervi E., Caccuri F., Bonardelli S., Landolfo S., Caruso A., Gribaudo G. Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor. J. Gen. Virol. 2011, 92:650-660.
24. Lee A.S., Kim D.H., Lee J.E., Jung Y.J., Kang K.P., Lee S., Park S.K., Kwak J.Y., Lee S.Y., Lim S.T., Sung M.J., Yoon S.R., Kim W. Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis. Cancer Res. 2011, 71:4506-4517.
25. Bashey A., Healy L., Marshall C.J. Proliferative but not nonproliferative responses to granulocyte colony-stimulating factor are associated with rapid activation of the p21ras/MAP kinase signalling pathway. Blood 1994, 83:949-957.
26. Grishin A., Sinha S., Roginskaya V., Boyer M.J., Gomez-Cambronero J., Zuo S., Kurosaki T., Romero G., Corey S.J. Involvement of Shc and Cbl-PI 3-kinase in Lyn-dependent proliferative signaling pathways for G-CSF. Oncogene 2000, 19:97-105.
27. van de Geijn G.J., Aarts L.H., Erkeland S.J., Prasher J.M., Touw I.P. Granulocyte colony-stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease. Rev. Physiol. Biochem. Pharmacol. 2003, 149:53-71.
28. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 1995, 268:251-255.
29. Nicholson S.E., Oates A.C., Harpur A.G., Ziemiecki A., Wilks A.F., Layton J.E. Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc. Natl. Acad. Sci. USA 1994, 91:2985-2988.
30. Carvalho T.T., Flauzino T., Otaguiri E.S., Batistela A.P., Zarpelon A.C., Cunha T.M., Ferreira S.H., Cunha F.Q., Verri W.A. Granulocyte-colony stimulating factor (G-CSF) induces mechanical hyperalgesia via spinal activation of MAP kinases and PI3K in mice. Pharmacol. Biochem. Behav. 2011, 98:188-195.
31. Klein J.B., Rane M.J., Scherzer J.A., Coxon P.Y., Kettritz R., Mathiesen J.M., Buridi A., McLeish K.R. Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways. J. Immunol. 2000, 164:4286-4291.